Pharmacokinetics/Charged particle radiation/Tumor/Gd-DTPA enhanced MR imaging.
INTRODUCTION
The Heavy Ion Medical Accelerator in Chiba (HIMAC) has been used to treat more than 1,000 patients. Encouraging results attest to its promising potential for cancer therapy with carbon-ion irradiation. [1] [2] [3] Carbon-ion irradiation has a high relative biological effectiveness (RBE), and its sharp Bragg Peak permits accurate beam localization in the tumor. This superior beam control has recently made it possible to reduce the number of radiation fractions (e.g., 60 Gy/4 fractions) 4) . Gadopentetate dimeglumine (Gd-DTPA) enhanced MRI also holds great promise as a useful method for the preirradiation assessment of radiosensitivity of the cancer and for measuring the postirradiation effectiveness of the treatment [5] [6] [7] Because the carbon-ion irradiation therapy has unique features such as a high RBE and a small number of fractions, it appears reasonable to anticipate similarly unique pharmacokinetics of Gd-DTPA. Carbon-ion irradiation is known to cause cellular and tissue responses different from those associated with usual photon irradiation, even when equivalent biological irradiation doses are given [8] [9] [10] [11] [12] . To determine the Gd uptake in carbon-ion irradiated tumors, we performed Gd-DTPA enhanced dynamic MRI on implanted tumors after irradiation with equivalent doses of carbon ions or γ-rays. Dynamic images were acquired 1 day (growth delay phase) and 6 days (regrowth phase) after irradiation. To permit a comparison with the results of conventional clinically enhanced MRI, maps of maximum-enhanced time (Tmax), relative signal intensity maximum (SImax), and time delay of enhancement (Td) were calculated by the use of pixel-by-pixel analysis.
MATERIALS AND METHODS

Animals and tumors
C3H/HeMsNrsf male mice aged 12-18 weeks were used for this study. The studies were reviewed and approved by the ethical committee for animal experiments in our institute. The animals were prepared and kept in specific pathogen-free (SPF) facilities. The tumor was a gynogenic NFSa fibrosarcoma, and its 16th through 18th generations were intramuscularly transplanted into the hind legs of the mice 7 days before irradiation. The implanted tumors were divided into five groups: C-1 (n = 6), C-6 (n = 6), γ-1 (n = 5), γ-6 (n = 6), and No-R (n = 6). C-1 and C-6 tumors were irradiated with carbon-ions 1 and 6 days prior, and γ-1 and γ-6 were irradiated with γ-rays 1 and 6 days prior, respectively, to MRI measurements. No-R tumors were not irradiated (controls). The mice irradiated with γ-rays were kept in SPF facilities, and the mice receiving carbon ions were transported to the accelerator facility shortly before irradiation.
Irradiation
The animals were irradiated with carbon-12 ions or Cs-137 γ-rays. The carbon-12 ions were accelerated with the HIMAC synchrotron up to 290 MeV/amu. Exposure was conducted by the use of horizontal carbon beams at a dose rate of approximately 3 Gy/min. 13) The physical dose declined to approximate 50% when the irradiation position was changed from the proximal edge of a 6 cm spread-out Bragg peak (SOBP) to the distal edge of the SOBP. The irradiation field was formed by the simultaneous use of an iron collimator and a brass collimator. The mice were immobilized under pentobarbital anesthesia (50 mg/kg) and taped on a Lucite plate to place their right hind legs in a rectangular field of 28 × 100 mm. The leg tumor received a dose of 16 Gy at a linear energy transfer (LET) of 74 keV/µm within the SOBP. The foot was excluded from the irradiation field.
Cs-137 γ-rays were applied at a dose rate of 1.6 Gy/min, and an FSD of 21 cm was used. A doughnut-shaped radiation field with a 30-mm rim was used to collimate the vertical beam. A dose of 30 Gy, having an equivalent effect in inducing tumor growth delay, was determined according to the data already reported (Fig. 1) 
13)
. The tumor volume increased one day after irradiation, then decreased till day 5 (growth delay phase) when it started to increase again (regrowth phase) at almost the same rate as the nonirradiated tumor.
Dynamic gadolinium-enhanced magnetic resonance imaging
The MR system used in this study was a Gyroscan ACS2 operated at 1.5 T (Philips Medical Systems, Ltd., Tokyo, Japan). A spin echo pulse sequence was used. The repetition 13) The tumor volume increased one day after irradiation, then decreased till day 5 (growth delay phase) when it started to increase again (regrowth phase) at almost the same rate as the nonirradiated tumor (doubling time was about 2.5 days).
Fig. 2.
Relative time-intensity curve and parameters. The plots in a and b are based on single-pixel data in different tumors. The data were fitted to a three-exponential curve to calculate the maximum enhanced time (Tmax), relative signal intensity maximum (SImax), and time delay of enhancement (Td). Tmax and SImax were obtained from the maximum peak of the fitted curve. Td was determined as the measurement time at which the mean signal intensity of the next three points was more than 130% of the prescan. Signal intensities for many pixels showed dynamic changes with no enhancement delay (a); for some pixels, however, especially in the C-1 group, there was a long enhancement delay (b).
and echo times were 120 msec and 20 msec, respectively. The slice thickness was 5 mm, and one signal acquisition was used. The matrix size was 128 × 256, and the field of view (FOV) was 140 mm. The tumor-bearing mice of all tumor groups were immobilized in the same manner under pentobarbital anesthesia (50 mg/kg) and by taping on Lucite plates. After 4 prescans, a manual bolus injection of Gd-DTPA (0.5 mmol/kg/10 sec) into the tail vein was performed, followed by dynamic MRI repeated every 20 sec for up to 10 min, then every 1 min from 10 to 30 min.
Maximum-enhanced time and relative signal intensity maximum
According to reports in the literature, the changes in Gd concentration in the extracelluar extravascular space (EES) are approximately consistent with a three-exponential curve. 14, 15) Therefore the dynamic signal change after Gd-DTPA injection was fitted to a three-exponential curve for each pixel, using the nonlinear least square method. Tmax and SImax were obtained from the maximum peak of the fitted curve. Since some pixels in the tumors showed a time delay in incipient enhancement (Td; Fig. 2 ), we determined Td in terms of the measurement time point at which the mean signal intensity of the next three points was more than 130% that in the prescan. The value of 30% for the signal intensity was approximately double the standard deviation in the prescan value.
Data analysis
To avoid a partial volume effect near the border of the tumor, 52 pixels were selected within a circle (diameter = 5 mm) inscribed in each tumor. The histograms of Tmax, SImax, and Td recorded all selected pixel data for all tumors in each group. The following variables were used for analysis: medians (Tmax, SImax, and Td), Tmax120s, and Td(+). Tmax120s and Td(+) represent the percentiles of Tmax in the range of 0-120 sec and the enhancement-delay-positive (Td > 0) pixels, respectively. The differences were determinedby the use of an analysis of variance (ANOVA) with the least significant difference (LSD) on a post hoc basis, with the variable being the irradiation condition (No-R, γ-1, γ-6, C-1, and C-6). The differences were considered to be significant at p < 0.05. 
RESULTS
Tumor sizes calculated from T1-weighted MR images were within a range of 200-320 mm 3 , and there were no significant differences among the groups (ANOVA).
All implanted tumors were enhanced in the dynamic MRI with Gd-DTPA, and the enhancement patterns were differently visualized for the different groups (Figs. 3, 4) . One day after carbon irradiation, Tmax in the tumor spread widely in such a manner that the flattest histogram (Fig. 4,  Tmax) and the largest median of Tmax were obtained among all tumor groups ( Table 1 ). The Tmax in C-1 tumors was significantly larger than those in the No-R, C-6, and γ-1 tumors (p < 0.01, ANOVA). The Td(+) value was 43.8% in the C-1 tumors (Fig. 4, Td) , which was significantly larger than the 4.2% value for the No-R group (p < 0.01, ANOVA) and the 9.2% value for the γ-1 group (p < 0.05, ANOVA). The median value of SImax for the C-1 group was the smallest among all groups, and a characteristic peak was obtained at 175-187.5% in the histogram. However, there was no significant difference in SImax (ANOVA). These Tmax and Td changes occurred mainly in the central part of the tumor.
The median value for C-6 Tmax distribution was the smallest among all groups. Seventy-seven percent of selected pixels showed Tmax values in the range of 0-120 sec (Tmax120s), significantly higher than the 25% in the No-R group (p < 0.01, ANOVA). All selected pixels in the C-6 group showed a Td(+) of 0%, indicating that the signal began to increase at the first scan after Gd-DTPA injection (Fig. 4,  Td) .
The Tmax maps in the tumors irradiated with γ-rays also showed a tendency to approximate those for the tumors irradiated with carbon ions (larger Tmax in γ -1, smaller Tmax in γ -6). A significant difference in Tmax120s was obtained between γ-1 and γ-6 (p < 0.05), though there was no significant difference from the nonirradiated tumor group. Slmax was similar for all tumors and was independent of radiation.
DISCUSSION
The Tmax and Td histograms for the C-1 group were different from those for the γ-1 group, though both types of radiation had been administered in equivalent doses. This point should be taken into account when assessing tumor changes after carbon-ion irradiation therapy. Dynamic enhancement of MRI associated with radiotherapy has already been extensively reported in the literature, and our observations confirmed these results. The low relative signal intensity 60-90 sec after Gd injection may suggest the presence of regions of poor vascularity within the tumor and can be used as a guide for predicting long-term tumor control and treatment outcome in cervical cancer. 7) The time delay at which enhancement (Td) set in may also be taken as a predictor for survival. 5) Hoskin et al. reported that local tumor control may be related to the value of SImax on a postradiotherapy scan and to the difference in Tmax between pre-and postradiotherapy scans. 9) These reports suggest that the large values of Tmax and Td are due to the low vascularity from severe tumor damage after irradiation. However, since Gd-DTPA biodistribution reflects the blood flow, vascular permeability, surface area of capillaries, and extracellular space, it is difficult to know the detailed contributions of these factors from only the dynamic enhanced MRI, and further studies, including histological analysis, will be needed. Tmax in the C-1 tumor spread widely, resulting in the flattest histogram. The Tmax enlargement occurred mainly in the central part of the tumor, and peripheral regions had Tmax relatively similar to the other groups. The flat histogram probably reflected the heterogeneity in C-1 Tmax. Small Tmax was obtained in the central part of C-1 tumors, but the reason for this is unclear. It may be that the peripheral regions are supplied with blood flow from adjacent tissue.
The tumor signal intensities of the γ-6 and C-6 groups increased rapidly after the i.v. injection of Gd-DTPA (Fig. 4 , Table 1 ). As shown in Fig.1 , the tumor volume 6 days postirradiation was almost the same as that of the No-R tumor, and the rate of increase was also quite similar. From this, it can be concluded that the physiological changes occurring after irradiation do not reflect tumor size. The transition of Gd-DTPA from plasma to the extravascular extracelluar space (EES) seems to depend on the permeability and surface area of the capillaries and on tumor blood flow. Photon irradiation is known to induce vascular growth. 16, 17) Ando et al. reported that carbon ions can stimulate the production of vascular endothelial growth factor (VEGF) in cultured human lung carcinoma cells after irradiation.
18) The resulting hypervascular status may lead to an increase in blood flow and capillary surface area, which may be responsible for the significant shortening of Tmax in the C-6 group. Changes in Gd-DTPA enhancement also correlate with oxygenation in some irradiated tumors. 19, 20) Ando et al. reported that carbon-ion irradiation accelerates reoxygenation to a greater extent than γ-ray The differences between the two groups were significant (p < 0.01).
e,h
The difference was significant (p < 0.05). Tmax, maximum enhancement time; SImax, maximum relative signal intensity; Td, time delay of enhancement.
irradiation. 8) The finding made in the present study that Tmax is shorter in the C-6 than in the γ-6 group is consistent with these reports.
The median Tmax value for the C-6 group was 71 sec, and the scan time (20 sec) used in this study for this group was relatively long for a complete kinetic analysis of such wellperfused tumors. With this slow time resolution, most of the data probably reflects only the diffusion of Gd-DTPA to the hypovascular parts. Higher time resolution is required for analyzing the pharmacokinetics in detail. Recently, T2* weighted EPI MRI has enabled us to obtain a dynamic enhanced MRI with a few seconds of time resolution. When Gd-DTPA is used as an intravascular tracer (e.g., brain) it is possible to measure the relative blood volume and perfusion. Gd-DTPA diffuses into the tumor's EES, and EPI signals are largely affected by the intravascular Gd concentration. This may complicate an analysis of the data. T1-weighted gradient echo can have good SNR and time resolution. However, when a gradient echo pulse sequence is used, there will be some T2*-weighted signal loss caused by Gd-DTPA . Even if Gd-DTPA is mainly located in vessels, the effect is extended to signals in tissues. This effect may cause some misunderstanding, especially in the early phase of DCE MRI when the concentration of Gd in the plasma is often higher than that in the tissue. Therefore we believe that the T1-weighted spin echo MRI reflects the Gd concentration in the tissue more purely than T1-weighted gradient echo MRI does, even though it has a poorer time resolution.
As mentioned above, the Tmax map showed dramatic changes according to the irradiation conditions, indicating its potential usefulness for the assessment of tumor radiosensitivity and recurrent growth. On the other hand, in SImax, histogram patterns similar to the No-R group were found in the maps of irradiated tumors. As Hoskin et al. reported, Tmax is useful as a predictor of the response to accelerated radiotherapy. 9) Tmax may thus be an important parameter for evaluating the physiological changes in the tumor after irradiation with carbon ions. Tmax is difficult to measure in clinical practice because Tmax values are larger in human tumors than in the tumors of small animals, and longer scan times are required. The relative signal changes at Tmax (= SImax) were similar among all tumor groups in this study, suggesting that Tmax has a direct bearing on the signal increase pattern in the early phase after Gd-DTPA injection. Under the limitations of the total scan time in the clinical setting, the signal increases in the early phase after irradiation may be more suitable than Tmax. Some studies have reported that the enhancement increase in the early phase (60-90 s) after injection can serve as a predictor of whether or not recurrence will take place in patients with cervical cancer 7) and point to a correlation between the increased enhancement and the microvessel density of human lung carcinoma. 21) Recent literature makes extensive reference to studies using quantitative analysis based on pharmacokinetic models. 22) The generally accepted compartmental model assumes that the Gd concentration in EES increases immediately after injection. 14, 15) In our present study, however, we found a nonincrease phase for a few minutes in some cases, especially in the C-1 group. This suggests that the assumption of the compartment model does not hold true in these kinds of regions. This initial zero-level plateau indicates a hypovascular status, and delayed enhancement may reflect diffusion to the hypovascular parts of the tumor.
In clinical use, a similar tendency of Gd-enhanced MRI would be shown, but the conditions about the effect of radiation on tumor and tumor vascularity are very different from those in animals. Therefore further human studies using the same parameters will be required for the evaluation of accuracy and usefulness.
CONCLUSION
We performed Gd-DTPA-enhanced dynamic MRI of carbon-irradiated tumor in mice and visualized the enhanced patterns in the form of Tmax, SImax, and Td maps. Significantly larger Tmax and Td values were found in the C-1 than in the No-R and γ-1 groups. A significant shortening of Tmax was observed in C-6 compared with the No-R and γ-1 groups. The Tmax maps for the tumors irradiated with γ-rays showed a tendency similar to that of the carbon-ion-irradiated tumors, and the changes were very minor. The pharmacokinetics of Gd-DTPA in the carbon-ion-irradiated tumor were different from those in the γ-ray-irradiated tumor, but both kinds of radiation produced similar growth delay. Treatment-specific kinetics may be useful in predicting therapeutic efficacy.
